Prosecution Insights
Last updated: April 19, 2026
Application No. 17/616,439

ULTRAVIOLET ABSORBER, PREPARATION METHOD THEREFOR, AND ULTRAVIOLET SCREENING PRODUCT CONTAINING SAME

Non-Final OA §103
Filed
Dec 03, 2021
Examiner
TRUONG, QUANGLONG N
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY
OA Round
2 (Non-Final)
79%
Grant Probability
Favorable
2-3
OA Rounds
2y 5m
To Grant
99%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
495 granted / 626 resolved
+19.1% vs TC avg
Strong +23% interview lift
Without
With
+23.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
49 currently pending
Career history
675
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
52.4%
+12.4% vs TC avg
§102
11.1%
-28.9% vs TC avg
§112
19.1%
-20.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 626 resolved cases

Office Action

§103
DETAILED ACTION Status of Application Claims 8 and 10 are cancelled. Claims 1, 3, 4, 5, 9, and 11 are amended. Claims 1-7, 9, and 11-14 are included in the prosecution. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments/Amendments Applicant’s amendments filed 9 September 2025 are sufficient to withdraw the previous rejections under 35 USC 112(b) over claims 3, 4, and 8. Examiner additionally relies on Couteau et al. (“Tris-biphenyl triazine, a new ultraviolet filter studied in terms of photoprotective efficacy” Int J Pharm. 2015 Jun 20;487(1-2):120-3. doi: 10.1016/j.ijpharm.2015.03.077. Epub 2015 Apr 2.) in a new ground of rejection, therefore this action is made NON-FINAL. Claim Rejections – 35 U.S.C. 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-7, 9, and 11-14 are rejected under 35 U.S.C. 103 as being unpatentable over Yuan et al. (“UV Protection of wood surfaces by graphitic carbon nitride nanosheets”, See 4/28/2023 IDS, page 2, reference 1) hereinafter Yuan. Regarding claim 1, Yuan discloses graphitic carbon nitride (g-CN) nanosheets were chosen as a novel non-toxic, green and low-cost UV absorber. Our research introduced a new UV absorber for wood products with efficient mechanism of UV protection. Resulting novel CW materials have good potential application prospects as functional wood products (abstract). Yuan discloses g-CN as a new metal-free UV absorber to protect wood substrate from the UV radiation. Heterogeneous interface structure was fabricated using hydrogen bonding between g-CN coating and wood surface by a simple hydrothermal method. The coated wood surface was subjected to the 15-day accelerated UV irradiation test. Protection efficiency was evaluated by the discoloration of the sample surface. Our results demonstrated that coatings with g-CN provided good protection to the underlying wood surfaces against UV light (pg 1070-1071; fig 1-8). Yuan does not explicitly disclose each of the components of the composition in a single embodiment for an anticipation rejection. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Yuan, to arrive at the instant invention. One of ordinary skill in the art would have been motivated to do so because Yuan discloses all the required ingredients and Yuan discloses experimental results confirmed presence of g-CN nanosheet coating on the wood surface. This coating was strongly bound to the wood surface by forming hydrogen bonds with underlying lignin and cellulose. After 15-day accelerated weathering test, the surface of g-CN coated wood (CW) did not show any visible discoloration, and the total color change (ΔE*) was less than 10%. g-CN nanosheets also enhanced wood thermal stability. Our research introduced a new UV absorber for wood products with efficient mechanism of UV protection. Resulting novel CW materials have good potential application prospects as functional wood products (abstract). Further, one having ordinary still in the art would reasonably expect success in combining prior art elements according to known methods to yield predictable results, see MPEP 2141. Regarding claim 2, Yuan discloses that bands located in the 1220–1630 cm−1 range of the FTIR spectrum of g-CN are assigned to the C-N stretching, typical for tri-s-triazine structures (pg. 1072; fig. 1). Regarding claims 3-4, Yuan discloses experimental results confirmed presence of g-CN nanosheet coating on the wood surface. This coating was strongly bound to the wood surface by forming hydrogen bonds with underlying lignin and cellulose. After 15-day accelerated weathering test, the surface of g-CN coated wood (CW) did not show any visible discoloration, and the total color change (ΔE*) was less than 10%. g-CN nanosheets also enhanced wood thermal stability. Our research introduced a new UV absorber for wood products with efficient mechanism of UV protection (abstract). One of ordinary skill in the art would reasonably expect that the sun protection factor of the g-CN nanosheet is 3.0 or more based on the experimental results of the 15 day accelerated weather test wherein the g-CN coated wood did not shower any visible discoloration, and the total color change was less than 10% as disclosed by Yuan. Regarding claims 5-7, 9, and 11-12, Yuan discloses bulk g-CN was synthesized by directly heating melamine according to a previous report. Melamine powder was placed into a semi-closed quartz crucible with a lid and heated to 550 °C for 2 h, at a heating rate of 10 °C /min. The obtained yellow agglomerates were ground to powder. Second, g-CN nanosheets were prepared by the chemical exfoliation method. 1 g of the bulk g-CN powder was mixed with 100 mL of H2SO4 in a 200 mL flask and stirred vigorously for 12 h at room temperature. Then, the mixture was slowly poured into a dialysis hoses and placed in a water bath, which was refreshed frequently until the pH of the solution was neutral. The resulting suspension was centrifuged at 4000 rpm to remove unexfoliated g-CN and dried at 60 °C for 12 h. Wood was covered with the g-CN-based coating by a simple hydrothermal method. 100 mg of the g-CN nanosheet powder was dispersed in 100 mL of deionized water and then was ultrasonically homogenized (pg. 1071). Regarding claims 13-14, Yuan discloses UV protection of wood surfaces by graphitic carbon nitride nanosheets (abstract), one of ordinary skill in the art would reasonably expect that the carbon nitride nanosheets are the ultraviolet blocking product and act as an ultraviolet blocking filter. Claims 1-7, 9, and 11-14 are rejected under 35 U.S.C. 103 as being unpatentable over Couteau et al. (“Tris-biphenyl triazine, a new ultraviolet filter studied in terms of photoprotective efficacy” Int J Pharm. 2015 Jun 20;487(1-2):120-3. doi: 10.1016/j.ijpharm.2015.03.077. Epub 2015 Apr 2.) hereinafter Couteau. Regarding claims 1-7, 9, and 11-14, Couteau discloses tris-biphenyl triazine. This filter is both very effective, as it enables 2 SPF units and 1 UVA-PF units to be obtained respectively, by percentage of use, and very photostable, since the SPF and UVA-PF do not vary after 2h of irradiation in a solar simulator. Its broad spectrum associated with its qualities in terms of efficacy and photostability make it a choice ingredient for the formulation of sun protection products (abstract). Couteau does not explicitly disclose each of the components of the composition in a single embodiment for an anticipation rejection. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Couteau, to arrive at the instant invention. One of ordinary skill in the art would have been motivated to do so because Couteau discloses all the required ingredients and Couteau discloses tris-biphenyl triazine as UV filter. This filter is both very effective, as it enables 2 SPF units and 1 UVA-PF units to be obtained respectively, by percentage of use, and very photostable, since the SPF and UVA-PF do not vary after 2h of irradiation in a solar simulator. Its broad spectrum associated with its qualities in terms of efficacy and photostability make it a choice ingredient for the formulation of sun protection products (abstract). Further, one having ordinary still in the art would reasonably expect success in combining prior art elements according to known methods to yield predictable results, see MPEP 2141. Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to QUANGLONG N TRUONG whose telephone number is (571) 270-0719. The examiner can normally be reached on 8:00 am-5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert A Wax can be reached on 571-272-0623. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /QUANGLONG N TRUONG/Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Dec 03, 2021
Application Filed
Jun 11, 2025
Non-Final Rejection — §103
Sep 09, 2025
Response Filed
Dec 13, 2025
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551418
COSMETIC COTAINING ULTRAVIOLET WAVELENGTH CONVERTING SUBSTANCE AND MEDICINAL AGENT
2y 5m to grant Granted Feb 17, 2026
Patent 12539322
USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE
2y 5m to grant Granted Feb 03, 2026
Patent 12533309
Minoxidil Adjuvant Therapies
2y 5m to grant Granted Jan 27, 2026
Patent 12533321
POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
2y 5m to grant Granted Jan 27, 2026
Patent 12527729
MINOXIDIL ADJUVANT THERAPIES
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
79%
Grant Probability
99%
With Interview (+23.2%)
2y 5m
Median Time to Grant
Moderate
PTA Risk
Based on 626 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month